Related Experiment Video
Updated: Apr 27, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Cystatin C at Admission in the Intensive Care Unit Predicts Mortality among Elderly Patients
Maria Aparecida Dalboni1, Daniel de Oliveira Beraldo1, Beata Marie Redublo Quinto1
1Universidade Federal de São Paulo, Botucatu Street, n740, Vila Clementino, 04023-062 São Paulo, SP, Brazil.
Insights
Serum cystatin C levels in elderly intensive care unit (ICU) patients do not predict acute kidney injury (AKI). However, elevated cystatin C independently predicts mortality, serving as a marker of poor prognosis in this population.
Area of Science:
- Nephrology
- Critical Care Medicine
- Geriatrics
Background:
- Serum cystatin C is utilized in critical care to assess renal function.
- Previous studies suggest a correlation between cystatin C and mortality.
- The precise mechanism linking cystatin C to mortality, whether via acute kidney injury (AKI) or other factors, remains unclear.
Purpose of the Study:
- To determine if serum cystatin C levels upon intensive care unit (ICU) admission predict AKI in elderly patients.
- To evaluate whether serum cystatin C predicts mortality in elderly ICU patients.
- To compare the predictive value of cystatin C versus AKI for mortality.
Main Methods:
- Prospective study involving elderly ICU patients without AKI at admission.
- Serum cystatin C levels were measured at ICU entry for 234 selected patients.
- Development of AKI and mortality were monitored; statistical analyses included ROC curves and hazard ratios.
Main Results:
- Higher serum cystatin C levels did not predict the development of AKI (P = 0.1).
- Serum cystatin C was an independent predictor of mortality (Hazard Ratio = 6.16, P = 0.01).
- AKI was not associated with death, while cystatin C showed a moderate predictive area for mortality (0.67, P = 0.03).
Conclusions:
- Elevated serum cystatin C levels are an independent predictor of mortality in elderly ICU patients.
- Serum cystatin C may serve as a valuable marker for poor prognosis in this patient group.
- The association of cystatin C with mortality appears independent of acute kidney injury.
Abstract:
Introduction. Cystatin C has been used in the critical care setting to evaluate renal function. Nevertheless, it has also been found to correlate with mortality, but it is not clear whether this association is due to acute kidney injury (AKI) or to other mechanism. Objective. To evaluate whether serum cystatin C at intensive care unit (ICU) entry predicts AKI and mortality in elderly patients. Materials and Methods. It was a prospective study of ICU elderly patients without AKI at admission. We evaluated 400 patients based on normality for serum cystatin C at ICU entry, of whom 234 (58%) were selected and 45 (19%) developed AKI. Results. We observed that higher serum levels of cystatin C did not predict AKI (1.05 ± 0.48 versus 0.94 ± 0.36 mg/L; P = 0.1). However, it was an independent predictor of mortality, H.R. = 6.16 (95% CI 1.46-26.00; P = 0.01), in contrast with AKI, which was not associated with death. In the ROC curves, cystatin C also provided a moderate and significant area (0.67; P = 0.03) compared to AKI (0.47; P = 0.6) to detect death. Conclusion. We demonstrated that higher cystatin C levels are an independent predictor of mortality in ICU elderly patients and may be used as a marker of poor prognosis.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction
Urine Studies II: Urine Culture and Sensitivity Test
